NTP studies find Chromax safe

PURCHASE, N.Y. Nutrition 21 on Thursday announced that study results released by the National Toxicology Program support the safety of short-term and long-term use of Chromium Picolinate.

“We are pleased with the conclusions of the NTP studies. Over the years Chromax chromium picolinate has proven to be an efficacious compound in assisting consumers to safely and proactively attain, and maintain, healthy blood glucose levels, carbohydrate metabolism, and body composition,” stated Michael Zeher, president and chief executive officer of Nutrition 21. “The results of these highly credible studies build upon the extensive database of safety data behind our products, and help provide retailers and consumers with the added confidence they need to initially buy our product and to become loyal repeat customers.”

Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements. Results of the studies can be viewed at the NTP website by clicking here.